Lippman Evan (CIK 2062834) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-18). Recent activity: Buy TEVA (11,841 shares), Sell TEVA (5,746 shares), Buy TEVA (74,008 shares), Sell TEVA (35,912 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | Buy | 11,841 | $0 |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | Sell | 5,746 | $204,467 |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | Buy | 74,008 | $0 |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | Sell | 35,912 | $1.3M |
Source: SEC Form 4 filings · as of 2026-05-18